Document is current
Any future updates will be listed below
-
Authors
Chen, Jack
Jastrzebska-Perfect, Patricia
Chai, Peter https://orcid.org/0000-0003-0955-4117
Say, Mehmet Girayhan
Tu, Jiaobing
Gao, Wei https://orcid.org/0000-0002-8503-4562
Halperin, Florencia
Korzenik, Joshua
Huang, Hen-Wei https://orcid.org/0000-0003-1921-8897
Katabi, Dina
Traverso, Giovanni https://orcid.org/0000-0001-7851-4077
- License Information
-
More Information
Article History
Received: 19 March 2024
Accepted: 28 August 2025
First Online: 14 November 2025
Competing interests
: G.T. has or currently receives equity/stock/royalties/gifts or board/advisor/consulting roles from Exact Sciences, Horizon, Pavoda, Entrega, CBSET, Avaxia, Lyndra, Novo Nordisk, SNS Nano, Hoffman la Roche, Janssen, Egalet, Synlogic, Suono Bio, Merck, Verily, Eagle Pharmaceuticals, Vivtex, Celero Systems, Bilayer Therapeutics, Teal Bio, Wired Consulting, Avadel Pharmaceuticals, Moderna, Syntis Bio, Vitakey, Absco Therapeutics, GEM-Bioscience, Bill and Melinda Gates Foundation, JHU technology transfer office, MIT technology licensing office and the MGB technology licensing office. F.H. is an employee of FormHealth. D.K. is a co-founder of Emerald. W.G. is a co-founder of Persperity Health.
